CubaHeadlines

Immunocompromised Adults

Latest updates on treatments and challenges for immunocompromised adults, including FDA approvals and breakthroughs in antiviral-resistant herpes therapies.

FDA Approves Hovilpri for Herpes Lesions Resistant to Antiviral Treatment in Immunocompromised Adults
FDA Approves Hovilpri for Herpes Lesions Resistant to Antiviral Treatment in Immunocompromised Adults

Published on 10/10/2026